Qiu Xiaoxia, Jin Guangxin, Zhang Xuebin, Xu Lichao, Ding Jinxia, Li Weisong, Yu Lejing, Wang Yapeng, Shen Yanfang, Wang Hongzhi, Wang Jue, Xu Haiping, Kong Weiwei, Yuan Lin, Bai Xuming, Liu Ye, Liu Hong, Cai Ming, Luo Feng, Yang Yiqun, Xiao Weizhu, Shen Lujun, Fang Yuying, Lin Jinxiang, Zhao Linfang, Qin Li, Gao Yana, Chang Lei, Dong Lei, Wei Hailing, Wei Lili
Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Affiliated Cancer Hospital of Fudan University, China.
J Interv Med. 2023 Apr 29;6(2):53-58. doi: 10.1016/j.jimed.2023.04.005. eCollection 2023 May.
With the widespread adoption of ultrasound guidance, Seldinger puncture techniques, and intracardiac electrical positioning technology for the placement of peripherally inserted central catheters in recent years, an increasing number of medical staff and patients now accept peripheral placement of totally implantable venous access devices (TIVADs) in the upper arm. This approach has the advantage of completely avoiding the risks of hemothorax, pneumothorax, and neck and chest scarring. Medical specialties presently engaged in this study in China include internal medicine, surgery, anesthesiology, and interventional departments. However, command over implantation techniques, treatment of complications, and proper use and maintenance of TIVAD remain uneven among different medical units. Moreover, currently, there are no established quality control standards for implantation techniques or specifications for handling complications. Thus, this expert consensus is proposed to improve the success rate of TIVAD implantation via the upper-arm approach, reduce complication rates, and ensure patient safety. This consensus elaborates on the technical indications and contraindications, procedures and technical points, treatment of complications, and the use and maintenance of upper-arm TIVAD, thus providing a practical reference for medical staff.
近年来,随着超声引导、塞丁格穿刺技术及心腔内电定位技术在经外周静脉穿刺中心静脉置管中的广泛应用,越来越多的医护人员和患者接受在上臂置入全植入式静脉输液港(TIVAD)。这种方法的优点是完全避免了血胸、气胸以及颈部和胸部瘢痕形成的风险。目前我国开展这项研究的医学专业包括内科、外科、麻醉科和介入科。然而,不同医疗单位在植入技术掌握、并发症处理以及TIVAD的正确使用和维护方面仍存在差异。此外,目前尚无植入技术的质量控制标准或并发症处理规范。因此,提出本专家共识,以提高上臂途径TIVAD植入的成功率,降低并发症发生率,确保患者安全。本共识详细阐述了上臂TIVAD的技术适应证和禁忌证、操作步骤及技术要点、并发症处理以及使用和维护,从而为医护人员提供实用参考。